In clinical trials, adults who used Wegovy alongside diet and lifestyle changes lost an average of 1415% of their body weight over one year.* Individual results vary based on factors such as dosage, adherence, lifestyle habits, and overall health
IGF-1 + Steroids (e.g., Testosterone, Anavar, Trenbolone) A full-spectrum PCT should be implemented: Tamoxifen (Nolvadex) 2040 mg/day for 46 weeks DHEA 100 mg/day ZMT To restore testosterone, improve sleep, and lower estrogenic rebound Combining IGF-1 analogs with suppressive anabolics alters HPTA signaling
Your doctor will discuss the expected timeline during your consultation
46-51 The first CV outcomes trial of a long-acting GLP-1 RA (semaglutide 2.4 mg/ week) in overweight/obese adults was published this year, 52 but participants with diabetes were excluded and the study cohort comprised only those with established CV disease (which included a combination of participants with stages A and B HF)
